Drugstore.com Investor Fights $409M Walgreen Deal
A shareholder filed a putative class action against Drugstore.com and its six-member board in Delaware on Friday, claiming Walgreen Co.'s $409 million planned acquisition "grossly undervalues" the online retailer and its...To view the full article, register now.
Already a subscriber? Click here to view full article